Total Payments
$2,873
2024 Payments
$491.27
Companies
26
Transactions
155
Medicare Patients
8,601
Medicare Billing
$875,640
Payment Breakdown by Category
Food & Beverage$2,873 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,873 | 155 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $533.65 | 38 | $0 (2023) |
| Novo Nordisk Inc | $476.83 | 9 | $0 (2024) |
| Boston Scientific Corporation | $357.37 | 15 | $0 (2024) |
| Amgen Inc. | $241.92 | 17 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $180.47 | 14 | $0 (2024) |
| PFIZER INC. | $109.47 | 8 | $0 (2024) |
| Merck Sharp & Dohme LLC | $102.60 | 7 | $0 (2024) |
| AtriCure, Inc. | $96.06 | 1 | $0 (2017) |
| Amarin Pharma Inc. | $91.81 | 7 | $0 (2021) |
| Kestra Medical Technology Services, Inc. | $90.45 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $491.27 | 22 | Boston Scientific Corporation ($231.19) |
| 2023 | $358.82 | 22 | Boston Scientific Corporation ($85.99) |
| 2022 | $428.73 | 13 | Novo Nordisk Inc ($249.66) |
| 2021 | $352.25 | 17 | Novo Nordisk Inc ($154.22) |
| 2020 | $317.52 | 23 | Janssen Pharmaceuticals, Inc ($113.53) |
| 2019 | $458.93 | 33 | Janssen Pharmaceuticals, Inc ($292.48) |
| 2018 | $290.80 | 18 | Medtronic Vascular, Inc. ($90.16) |
| 2017 | $174.45 | 7 | AtriCure, Inc. ($96.06) |
All Payment Transactions
155 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $119.09 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 11/25/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.81 | General |
| Category: Obesity | ||||||
| 11/01/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.41 | General |
| Category: Cardiovascular | ||||||
| 10/24/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 09/18/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.77 | General |
| Category: Obesity | ||||||
| 09/12/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: Cardiology | ||||||
| 07/24/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: Cardiology | ||||||
| 06/13/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/07/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 05/30/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $34.85 | General |
| Category: Cardiology | ||||||
| 05/23/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $24.46 | General |
| Category: Obesity | ||||||
| 05/16/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/10/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $13.86 | General |
| Category: Cardiovascular | ||||||
| 04/18/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: Cardiology | ||||||
| 04/17/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/14/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: Diabetes | ||||||
| 04/04/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 02/28/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: Cardiology | ||||||
| 02/16/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 01/20/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 01/12/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $14.16 | General |
| Category: Cardiovascular | ||||||
| 01/11/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 12/21/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $17.23 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/10/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $13.02 | General |
| Category: Cardiology | ||||||
| 10/24/2023 | Boston Scientific Corporation | WATCHMAN (Device) | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: WATCHMAN Pro_IC | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,372 | 1,782 | $541,686 | $170,463 |
| 2022 | 18 | 1,740 | 2,172 | $654,240 | $198,058 |
| 2021 | 20 | 2,660 | 3,572 | $739,365 | $236,183 |
| 2020 | 20 | 2,829 | 4,007 | $853,920 | $270,936 |
Total Patients
8,601
Total Services
11,533
Medicare Billing
$875,640
Procedure Codes
88
All Medicare Procedures & Services
88 procedure records from CMS Medicare Utilization — Page 2 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2022 | 87 | 348 | $21,750 | $16,448 | 75.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 157 | 162 | $44,550 | $9,597 | 21.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 67 | 88 | $14,080 | $9,452 | 67.1% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2022 | 163 | 163 | $57,050 | $9,286 | 16.3% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2022 | 105 | 105 | $12,390 | $8,962 | 72.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 70 | 71 | $15,975 | $8,194 | 51.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 108 | 121 | $13,310 | $7,203 | 54.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 12 | 16 | $7,200 | $2,996 | 41.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 16 | 16 | $3,600 | $2,381 | 66.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 14 | 14 | $4,270 | $2,222 | 52.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 15 | 15 | $3,750 | $2,114 | 56.4% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 238 | 279 | $11,160 | $1,955 | 17.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 11 | 11 | $2,475 | $1,388 | 56.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 78 | 87 | $6,525 | $1,064 | 16.3% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2022 | 12 | 12 | $4,800 | $670.99 | 14.0% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2022 | 13 | 13 | $975.00 | $192.43 | 19.7% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2022 | 13 | 13 | $2,340 | $137.99 | 5.9% |
| 78452 | Nuclear medicine study of vessels of heart using drugs or exercise multiple studies | Office | 2021 | 124 | 124 | $186,000 | $54,845 | 29.5% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Office | 2021 | 159 | 159 | $174,900 | $26,151 | 15.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 174 | 265 | $40,890 | $23,043 | 56.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 123 | 130 | $39,000 | $21,998 | 56.4% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2021 | 109 | 436 | $27,250 | $20,475 | 75.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 191 | 276 | $28,710 | $16,891 | 58.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 98 | 109 | $16,370 | $11,022 | 67.3% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Facility | 2021 | 157 | 159 | $43,725 | $9,396 | 21.5% |
About Dr. Arpit Patel, M.D
Dr. Arpit Patel, M.D is a Cardiovascular Disease healthcare provider based in Piscataway, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/31/2012. The National Provider Identifier (NPI) number assigned to this provider is 1194074591.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Arpit Patel, M.D has received a total of $2,873 in payments from pharmaceutical and medical device companies, with $491.27 received in 2024. These payments were reported across 155 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($2,873).
As a Medicare-enrolled provider, Patel has provided services to 8,601 Medicare beneficiaries, totaling 11,533 services with total Medicare billing of $875,640. Data is available for 4 years (2020–2023), covering 88 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Piscataway, NJ
- Active Since 08/31/2012
- Last Updated 06/05/2025
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1194074591
Products in Payments
- XARELTO (Drug) $533.65
- Rybelsus (Drug) $249.66
- WATCHMAN FLX (Device) $231.19
- Repatha (Biological) $200.88
- ELIQUIS (Drug) $166.37
- RYBELSUS (Drug) $139.75
- VERQUVO (Drug) $102.60
- WATCHMAN (Device) $101.75
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX, MODELS (Device) $96.06
- Vascepa (Drug) $91.81
- Assure WCD (Device) $90.45
- Resolute (Device) $90.16
- LifeVest (Device) $85.74
- CAMZYOS (Drug) $81.62
- Wegovy (Drug) $58.04
- PRALUENT (Drug) $53.72
- ENTRESTO (Drug) $51.60
- BRILINTA (Drug) $51.57
- Corlanor (Drug) $41.04
- FUROSCIX (Drug) $34.52
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.